SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Assertio Therapeutics Q1 EPS $0.10 Beats $(0.08) Estimate, Sales $20.917M Beat $11.300M Estimate

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.100 per share which beat the analyst consensus estimate of $(0.080) by 225 percent. This is a 56.52 percent decrease over earnings of $0.230 per share

Benzinga · 05/11/2020 12:12

Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.100 per share which beat the analyst consensus estimate of $(0.080) by 225 percent. This is a 56.52 percent decrease over earnings of $0.230 per share from the same period last year. The company reported quarterly sales of $20.917 million which beat the analyst consensus estimate of $11.300 million by 85.11 percent. This is a 63.89 percent decrease over sales of $57.929 million the same period last year.